144 related articles for article (PubMed ID: 8707743)
1. Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
Cook PJ; Andrews JM; Wise R; Honeybourne D
J Antimicrob Chemother; 1996 Feb; 37(2):331-9. PubMed ID: 8707743
[TBL] [Abstract][Full Text] [Related]
2. Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection.
Cook PJ; Andrews JM; Woodcock J; Wise R; Honeybourne D
Thorax; 1994 Nov; 49(11):1134-8. PubMed ID: 7831630
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
[TBL] [Abstract][Full Text] [Related]
4. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.
Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R
J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens.
Baldwin DR; Andrews JM; Wise R; Honeybourne D
J Antimicrob Chemother; 1992 Sep; 30(3):377-85. PubMed ID: 1452503
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
[TBL] [Abstract][Full Text] [Related]
7. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
[TBL] [Abstract][Full Text] [Related]
8. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
[TBL] [Abstract][Full Text] [Related]
9. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
[TBL] [Abstract][Full Text] [Related]
10. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy.
Ziglam HM; Baldwin DR; Daniels I; Andrew JM; Finch RG
J Antimicrob Chemother; 2002 Dec; 50(6):1011-5. PubMed ID: 12461025
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.
Andrews J; Honeybourne D; Jevons G; Boyce M; Wise R; Bello A; Gajjar D
J Antimicrob Chemother; 2003 Mar; 51(3):727-30. PubMed ID: 12615879
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
[TBL] [Abstract][Full Text] [Related]
14. The penetration of cefpirome into the potential sites of pulmonary infection.
Baldwin DR; Maxwell SR; Honeybourne D; Andrews JM; Ashby JP; Wise R
J Antimicrob Chemother; 1991 Jul; 28(1):79-86. PubMed ID: 1769946
[TBL] [Abstract][Full Text] [Related]
15. Lung concentrations of telithromycin after oral dosing.
Khair OA; Andrews JM; Honeybourne D; Jevons G; Vacheron F; Wise R
J Antimicrob Chemother; 2001 Jun; 47(6):837-40. PubMed ID: 11389116
[TBL] [Abstract][Full Text] [Related]
16. Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).
Muller-Serieys C; Soler P; Cantalloube C; Lemaitre F; Gia HP; Brunner F; Andremont A
Antimicrob Agents Chemother; 2001 Nov; 45(11):3104-8. PubMed ID: 11600363
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Pulm Pharmacol Ther; 2007; 20(5):549-55. PubMed ID: 17127087
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
20. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.
Rodvold KA; George JM; Yoo L
Clin Pharmacokinet; 2011 Oct; 50(10):637-64. PubMed ID: 21895037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
